Management status and its predictive factors in patients with type 2 diabetes in China: A Nationwide Multicenter Study

Background The prevalence of type 2 diabetes in China is increasing rapidly. Appropriate management of glycemia, blood pressure and dyslipidemia in this population is a major public health concern. Objective The aim of this study was to assess metabolic control including glycated hemoglobin A1c (HbA...

Full description

Saved in:
Bibliographic Details
Published in:Diabetes/metabolism research and reviews 2015-11, Vol.31 (8), p.811-816
Main Authors: Liu, Lin, Lou, Qingqing, Guo, Xiaohui, Yuan, Li, Shen, Li, Sun, Zilin, Zhao, Fang, Dai, Xia, Huang, Jin, Yang, Huiying, Mordes, John P.
Format: Article
Language:English
Subjects:
blood pressure
cholesterol
hemoglobin A1c
type 2 diabetes
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background The prevalence of type 2 diabetes in China is increasing rapidly. Appropriate management of glycemia, blood pressure and dyslipidemia in this population is a major public health concern. Objective The aim of this study was to assess metabolic control including glycated hemoglobin A1c (HbA1c), blood pressure (BP) and low density lipoprotein cholesterol (LDL‐c), in a large sample of patients with type 2 diabetes in China and to identify factors that correlated with the achievement of HbA1c, BP and LDL‐c goals (ABCs). Method A nationwide survey was conducted in 50 medical centres across China from April to July of 2010. Baseline information on demographics, medical history, HbA1c, BP and LDL‐c levels were measured in 5961 patients with type 2 diabetes. Results Mean age, body mass index (BMI) and HbA1c were 59.5 ± 1.3 years, 24.5 ± 4.1 kg/m2 and 8.3 ± 2.2%, respectively. With respect to generally accepted ABC treatment goals, 35.2% of participants had HbA1c
ISSN:1520-7552
1520-7560
DOI:10.1002/dmrr.2757